{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:20:42Z","timestamp":1770510042277,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.pnpbp.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T20:00:34Z","timestamp":1402948834000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in the mouse forced swimming test is mediated by serotonergic and dopaminergic systems"],"prefix":"10.1016","volume":"54","author":[{"given":"Ana Paula","family":"Pesarico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuane Bazanella","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eluza Curte","family":"Stangherlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson C.","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilson","family":"Zeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Wayne","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2014.06.001_bb0005","first-page":"185","article-title":"Recent assessments on the neurobiology of major depression: a critical review","volume":"43","author":"Altamura","year":"2008","journal-title":"Riv Psichiatr"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0924-977X(99)00048-6","article-title":"Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice","volume":"10","author":"Alvarez","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejphar.2012.10.017","article-title":"Anti-depressant-like effect of vitexin in BALB\/c mice and evidence for the involvement of monoaminergic mechanisms","volume":"699","author":"Can","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejphar.2010.06.043","article-title":"Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems","volume":"643","author":"Capra","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0030","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","article-title":"Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors","volume":"295","author":"Cryan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2010.05.003","article-title":"Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: involvement of serotonergic system","volume":"59","author":"Gay","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejphar.2011.11.009","article-title":"The antidepressant-like effect of Hedyosmum brasiliense and its sesquiterpene lactone, podoandin in mice: evidence for the involvement of adrenergic, dopaminergic and serotonergic systems","volume":"674","author":"Goncalves","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0080","first-page":"79","article-title":"The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation","volume":"96","author":"Gray","year":"1962","journal-title":"J Anat"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0924-977X(00)00079-1","article-title":"The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission","volume":"10","author":"Joca","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0090","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin\u2013dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)27497-3","article-title":"p-Chlorophenylalanine: a specific depletor of brain serotonin","volume":"154","author":"Koe","year":"1966","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/0006-2952(65)90025-0","article-title":"A rapid microfluorimetric determination of monoamine oxidase","volume":"14","author":"Krajl","year":"1965","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ptr.2968","article-title":"Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders","volume":"24","author":"Kulkarni","year":"2010","journal-title":"Phytother Res"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pnpbp.2006.11.004","article-title":"Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system","volume":"31","author":"Machado","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/87865","article-title":"The cellular neurobiology of depression","volume":"7","author":"Manji","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejps.2013.09.021","article-title":"Synthesis of pharmacologically active 1-amino-isoquinolines prepared via silver triflate-catalyzed cyclization of o-alkynylbenzaldoximes with isocyanates","volume":"51","author":"Mantovani","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0003-2697(84)90780-2","article-title":"3-(p-hydroxyphenyl)propionic acid as a new fluorogenic reagent for amine oxidase assays","volume":"138","author":"Matsumoto","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","article-title":"The burden of severe depression: a review of diagnostic challenges and treatment alternatives","volume":"41","author":"Nemeroff","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0145","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.pnpbp.2005.03.017","article-title":"New drug targets in the signaling pathways activated by antidepressants","volume":"29","author":"Paez-Pereda","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0150","first-page":"727","article-title":"Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds\u20141,2,3,4-tetrahydro-isoquinoline alkaloids","volume":"56","author":"Patsenka","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0155","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.lfs.2004.04.032","article-title":"Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors","volume":"75","author":"Peng","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0160","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050638","article-title":"Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity","volume":"138","author":"Redrobe","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0175","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.pnpbp.2007.05.006","article-title":"Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats","volume":"31","author":"Savegnago","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","article-title":"Monoamine oxidase: from genes to behavior","volume":"22","author":"Shih","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0024-3205(01)01178-X","article-title":"Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress","volume":"69","author":"Soto-Otero","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0190","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/brain\/awm150","article-title":"Blunted response to feedback information in depressive illness","volume":"130","author":"Steele","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0195","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.brainresbull.2008.08.012","article-title":"Involvement of adrenergic and serotonergic receptors in antidepressant-like effect of urocortin 3 in a modified forced swimming test in mice","volume":"77","author":"Tanaka","year":"2008","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pnpbp.2012.04.007","article-title":"Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice","volume":"39","author":"Villarinho","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2007.08.045","article-title":"The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors","volume":"578","author":"Wang","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2012.11.063","article-title":"Antidepressant-like activity of the endogenous amine, 1-methyl-1,2,3,4-tetrahydroisoquinoline in the behavioral despair test in the rat, and its neurochemical correlates: a comparison with the classical antidepressant, imipramine","volume":"700","author":"Wasik","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0215","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1211\/jpp.61.07.0001","article-title":"Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research","volume":"61","author":"Ye","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0220","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0006-8993(96)00762-7","article-title":"Possible involvement of calmodulin-dependent kinases in Ca(2+)-dependent enhancement of [3H]5-hydroxytryptamine uptake in rat cortex","volume":"738","author":"Yura","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.bmc.2011.12.039","article-title":"Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A\/5-HT2A\/5-HT7 and D2\/D3\/D4-agents: the synthesis and pharmacological evaluation","volume":"20","author":"Zajdel","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pnpbp.2014.06.001_bb0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2012.11.042","article-title":"Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT(1)A\/5-HT(2)A\/5-HT(7) and dopamine D(2)\/D(3) receptors","volume":"60","author":"Zajdel","year":"2013","journal-title":"Eur J Med Chem"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584614001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584614001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T10:32:15Z","timestamp":1746268335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584614001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":45,"alternative-id":["S0278584614001201"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2014.06.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in the mouse forced swimming test is mediated by serotonergic and dopaminergic systems","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}